
BIOTRICITY INC by Biotricity fell 90.0% from $0.56 to $0.06, behind the S&P 500's +10.5%. Its worst day was May 20 (−35.1%), and its low came Oct 12 at $0.04.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.03 was reported on $3.9M revenue (est. $3.9M).
+7.9% · S&P 500 0.0%
BIOTRICITY INC by Biotricity shares fell 20.2%, while the S&P 500 rose 0.7%.
−20.2% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-0.04 beat the $-0.08 estimate on $4.0M revenue (est. $4.1M).
0.0% · S&P 500 −1.5%
BIOTRICITY INC by Biotricity shares fell 35.1%, while the S&P 500 rose 1.0%.
−35.1%, the year's worst day, on 733K shares, the year's heaviest volume · S&P 500 +1.0%
BIOTRICITY INC by Biotricity shares rose 22.6%, while the S&P 500 rose 0.1%.
+22.6%, the year's best day · S&P 500 +0.1%
BIOTRICITY INC by Biotricity shares rose 21.0%, while the S&P 500 rose 0.4%.
+21.0% · S&P 500 +0.4%
BIOTRICITY INC by Biotricity closed at its lowest level of the year, 92.0% below where the year started.
−14.9% · S&P 500 −0.1%
Where it ended: a close of $0.06 on Nov 9, 2026.
Nothing in the past 12 months.
All BTCY analyst actionsNothing in the past 12 months.
All BTCY dividend history